Moderna's cancer vaccine data revealed, causing dramatic fluctuations in trading volume for mRNA contracts on Hyperliquid.

Moderna's cancer vaccine clinical data was released at 00:30. On Hyperliquid, 362,000 mRNA contracts were traded in three hours, with a peak 24-hour trading volume of $104 million. The notional open interest of mRNA contracts surged from $6.84 million to $20.31 million, and open interest increased from 30,500 contracts to 108,800 contracts, before subsequently falling back to $6.27 million and 30,900 contracts. One account established a short position of 6,310.91 mRNA contracts, worth approximately $1.283 million, with an average entry price of $188.304, and is currently experiencing a floating loss of approximately $95,000.